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IN this study levels of prostaglandin E2 (PGE2), tumour
necrosis factor (TNF) and interleukin-1 (IL-1) alpha in
medium from monocyte derived macrophages (MdM)
infected with Chlamydia trachomatis (Ld434/Bu or K
biovars). TNF and PGE2 were found in both cases while
IL-1 alpha was not detected. Both TNF and PGE2 levels
were higher in the medium of the MdM infected with K
biovars. TNF reached maximum levels 24h post-
infection, and then declined, while PGE2 levels increased
continuously during the infection time up to 96h
post-infection. Addition of dexamethasone inhibited
production of TNF and PGE2. Inhibition of PGE2
production by indomethacin resulted in increased
production ofTNF, while addition ofPGE caused partial
inhibition of TNF production from infected MdM.
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Introduction
Different biovars of Chlamydia trachomatis, an
obligate intracellular Gram-negative bacterium,
have been associated with clinically distinct
infections ranging from hyperendemic trachoma
(serovars A, B, and C) to sexually transmitted
infections and pneumonia (serovars D to K).
Lymphogranuloma venereum is a sexually trans-
mitted disease caused by C. trachomatis serovars El,
L2 and L3, which are more invasive than biovars
D to K. Lymphogranuloma venereum causes a
systemic infection characterized primarily by gross
lymphadenopathy, suppurative adenitis, and ulcera-
tive genital tract and rectal diseases.
The mononuclear phagocytes, including both the
tissue macrophages and their precursors, the
circulating blood monocytes, act as effective
microbicidal host defence cells against many
pathogenic microorganisms. They have been
implicated in regulating the functions of lymphoid
and haematopoietic cells, and in most cases, these
effects are mediated by soluble factors produced by
circulating monocytes and tissue macrophages.
2
Endotoxin and lipopolysaccharide of the outer
membrane of Gram-negative bacteria have been
found to potently stimulate human monocytes to
produce several substances with important bio-
logical activities,
3 including interleukin 1 (IL-1),
4,s
tumour necrosis factor (TNF)6’7 and prostaglandin
E2 (PGE2).
8 These factors induce a multitude of
biological responses of importance in homeostasis,
in host defence mechanisms, and, probably, in the
pathogenesis of several diseases.
9-1
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The present study shows that infection of human
monocyte derived macrophages (MdM) with L2
or K biovars induces the production of TNF and
PGE2 but not of IL-1 alpha. The effect of
dexamethasone on the production of these factors
in MdM has also been examined.
Materials and Methods
Cells: HEp-2 cells, originating from human
carcinoma of the larynx (Flow Laboratories, UK,
03-108) were grown in minimal essential medium
(MEM) with glutamine and antibiotics (Biological
Industries, Belt Haemek, Israel), and 10% foetal calf
serum (FCS) (Gibco Laboratories, Grand Island,
NY, USA).
Human rnonocytes were prepared from hepar-
inized blood of normal donors as described
previously.
2 Monocytes grown in RPMI-1640
medium supplemented with 10% heat inactivated
foetal calf serum, glutarnine and antibiotics,
incubated at 37C in an atmosphere of 5% CO2
for 8-10 days were used as MdM.
Preparation of purified, infectious EB particles: Infectious
C. trachomatis biovar lymphogranuloma venereum
(L2/434/Bu) and serum K elementary body particles
were purified from BGM cells as described
previously.
2
Immunoperoxidase assay for titration of C. trachomatis: C.
trachomatis was titrated on HEp-2 cells as described
previously,
a2 The final results of titration were
expressed as inclusion-forming units per millilitre.
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Chlamydial infection in MdM and control cells: MdM
(8 x 10s cells/well) and HEp-2 cells (2 x 10
cells/well) were grown in 24-well plates (Nunc,
Denmark). Twenty-four h later the cells, treated or
not treated with either dexamethasone (10
-6 M),
indomethacin (10
-6 M) or PGE2 (10
-6 M), were
infected or not infected with L2 or K biovars at a
multiplicity of infection (M.O.I.) of 1-2. Two h
later the unadsorbed Chlamydiae were removed,
and fresh medium with or without dexamethasone
(10
-6 M), indomethacin (10
-6 M) or PGE2 (10
-6
M), respectively, was added to the wells. At
various time intervals (2, 24, 48 and 96h
post-infection) medium from the wells was
harvested and centrifuged for 5 min at 20 000 x ,.
The supernatant was frozen at -70C until PGE.,
TNF or IL-1 alpha were measured.
Determination of TNF, PGEe and IL-I alpha: TNF
concentrations were determined by ELISA (Bio-
kine TNF Test Kit, T Cell Sciences, Inc.,
Cambridge, MA, USA). Cell free culture medium
from the kinetic studies was subjected to RIA for
PGE2 analysis as described previously.
13 IL-1 alpha
concentrations were determined by ELISA (Endo-
gen Inc., Boston, MA, USA).
Results
PGEe production from MdM infected with Chlamydiae:
MdM untreated or treated with dexamethasone
(10
-6 M) or indomethacin (10
-6 M), were infected
or mock infected with C. trachomatis (g2 or K
biovars) at a M.O.I. of 1-2. At various time
intervals (2, 24, 48, 96 h post-infection) medium was
harvested and PGE2 levels were determined by RIA
in the cell-free medium. Fig. 1 shows that the
amount of PGE2 in the medium from L2 and K
infected MdM increased during the infection time.
Infection with the K biovar resulted in higher levels
of PGE2 secretion. Infection of the MdM with a
higher M.O.I. s of both t2 or K biovars resulted in
an increase of PGE2 production (data not shown).
Daily medium replacement resulted in lower PGE2
production per 24h from the infected MdM
compared with the infected cells in which no
medium was replaced (data not shown). Addition
of dexamethasone (10-6M) or indomethacin
(10
-6 M) to the chlamydial infected MdM (K or L.)
resulted in complete inhibition ofPGE2 production.
The effect of dexamethasone and indomethacin on
PGE2 production observed in MdM infected with
the K biovar was much more pronounced than that
observed in MdM infected with the L2 biovar. This
phenomenon was caused by the reduced ability of
the L2 biovar to stimulate PGE production in
MdM compared to the K biovar. Fig. 2 shows the
et:Fect of dexamethasone and indomethacin on PGE2
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FIG. 1. PGE2 release from MdM infected with C. trachomatis L (343/Bu)
or K biovars at a M.O.I. of 1-2. A, PGE2 release from MdM infected
with K biovar; A, PGE2 release from MdM infected with L2 biovar; (C),
mock infected MdM.
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FIG. 2. PGE2 release from MdM infected with C. trachomatis K biovar:
the effect of dexamethasone or indomethacin treatment. O, PGE2 release
from infected MdM without treatment; A, PGE2 release from infected
MdM treated with dexamethasone; F’I, PGE2 release from infected MdM
treated with indomethacin; mock infected MdM.
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levels in cell free medium from MdM infected with
the K biovar. Medium from control mock infected
MdM with or without dexamethasone or in-
domethacin had low levels ofPGE2 (0-0.6 ng/ml).
TNF production by MdM infected with Chlamydiae: TNF
was measured by ELISA in parallel with PGE2
determination. Both L2 and K biovars induced
production ofTNF by MdM. TNF production was
higher in the MdM infected with the K strain. TNF
reached maximum levels 24 h post-infection (Fig.
3) and then declined. Daily replacement of the
medium from the infected cells with fresh medium
resulted in higher levels of TNF (data not shown).
Infection at a higher M.O.I. of both L2 and K
strains resulted in higher TNF production (data not
shown).
Addition of dexamethasone (10-6M) to the
Chlamydia infected MdM resulted in inhibition of
TNF production, while addition of indomethacin
(10
-6 M) resulted in an increase of TNF produc-
tion. Addition of PGE2 (10
-6 M) to the Chlamydia
infected MdM resulted in partial inhibition of TNF
production. The effect of dexamethasone and
indomethacin on TNF production observed in
MdM infected with the K biovar was much more
pronounced than that observed in MdM infected
with the t2 biovar. Fig. 4 shows the effect of
dexamethasone, indomethacin and PGE2 on the
TNF level in the medium from MdM infected with
biovar K. In medium from mock infected MdM
treated or not treated with dexamethasone,
indomethacin or PGE2, no TNF was detected.
Determination of IL-1 alpha in the cell free medium of
chlamydia infected or mock infected MdM: The levels of
IL-1 alpha in the medium ofK or L2 infected or
mock infected cells was detected by ELISA in
parallel with TNF and PGE2 determination. No
difference was found between the 1L-1 alpha levels
in the mock infected compared to the Chlamydia
infected MdM medium.
Chlamydial yield in MdM with or without dexamethasone,
indomethacin or PGE2 treatment: MdM were treated or
not treated with dexamethasone (10-6M), in-
domethacin (10
-6 M) or PGE2 and infected with C.
trachomatis K and t2 biovars at a M.O.I. of 1-2.
Ninety-six h later triplicates of each treatment were
harvested and the chlamydial yield was determined.
L2 reached a yield of 1-2 x 10 IFU/ml while only
20-50 IFU/ml were detected in the MdM infected
with the K biovar. Treatment with indomethacin
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FIG. 3. TNF release from MdM infected with C. trachomatis L (343/Bu)
or K biovars. (C), TNF release from MdM infected with K biovar; 0, TNF
release from MdM infected with L biovar; TNF release from mock
infected MdM.
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FIG. 4. TNF release from MdM infected with C. trachomatis K biovar’ the
effect of dexamethasone (Dex), indomethacin (Indo) or PGE2, 24h
post-infection. Control without treatment (NT). ll,, Infected cells;.,
control cells.
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and PGE2 did not affect chlamydial yield, while
treatment with dexamethasone resulted in a 2- to
3-fold increase in chlamydial yield of both K and
L2 biovars.
Discussion
Various biovars of C. trachomatis differ in their
pathogenicity, but the mechanism is still obscure.
One possible explanation might be the ability of the
pathogen to turn on host defence mechanisms. The
mechanisms of the host defence against diseases
caused by chlamydial species are not clearly
understood, but both humoral and cell mediated
immunity are involved. TM Infection of macrophages
by intracellular parasites might modulate produc-
tion of TNF, PGE2 and IL-1 alpha, which, in turn,
might have a profound effect on the outcome of the
infection in vivo.
The present study shows clearly that L2 and K
biovars induced production of TNF from human
MdM (Figs 1 and 3). This production increased
when a higher multiplicity of infection of Chlamydia
was used. Higher levels were observed in the case
ofK strain infected MdM. This might explain the
inability ofK strain to grow in MdM, as described
by us (Schmitz, Manor, Sarov [Abstract, Germany],
and Yong) as well as the difference in the
severity of the outcome of the infection in vivo
between the t2 and K biovars--L, causing a more
generalized infection than K. Recently, Williams et
al.
is showed that spleen cells from C. trachomatis,
pneumonitis agent infected nu/+ and nu/nu mice
produced TNF-. They suggested that TNF-
might play a role in host defence in the murine
model. It has been shown that TNF- inhibits
chlamydial growth in HEp-2 cells.
16 This suggests
that in vivo, early in the chlamydial infection, TNF
may play a protective role. However, it is also likely
that TNF might cause some of the pathological
effects seen in the course of chlamydial infection.
The capability of Chlamydiae to induce TNF
production from macrophages is not unique to
chlamydiae, but has been demonstrated recently in
a wide range of intracellular pathogens such as
viruses,
7 bacteria,
-2 eukaryotic parasites,
2 and
fungi.
22 Various molecules have also been found to
be able to induce TNF in macrophages, such as
bacterial lipopolysaccharides and endotoxin.
23 Fur-
ther studies are required to characterize the
chlamydial component responsible for the induc-
tion of TNF- in human macrophages.
This study shows that L2 and K also induced
human MdM to produce PGE2 (Fig. 1). The level
of PGE2 increased when a higher multiplicity of
infection of Chlamydiae was used. The PGE2 level
was higher when MdM were infected with the K
strain. PGE2 has been shown to be produced by
macrophages infected with viruses,24’2s bacteria,
26
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and intracellular parasites,27’28 and may cause
profound metabolic and functional changes in these
cells.
29
Dexamethasone inhibited TNF and PGE2
production (Figs 2 and 4). These results are in
agreement with those described by Beutler et al.3
and by Danon et al.,
3 respectively who have
shown that dexamethasone inhibits TNF and
PGE2 production at the transcriptional level.
Only L2 was found to replicate in MdM.
12
Treatment of the cells with dexamethasone
enhanced the yield of infectious chlamydial
particles in these cells. These results cannot be
simply explained by the dexamethasone inhibition
ofTNF production from chlamydial infected MdM.
This conclusion is based on the findings that
addition of an excess of PGE2, which inhibits TNF
production, or indomethacin, which enhances TNF
production, did not affect the chlamydial yield in
MdM. The mechanism by which dexamethasone
enhances chlamydial yield in MdM needs further
investigation. Corticosteroids have been found to
enhance replication of viruses,
32 and certain
intracellular parasites.
3-3s
In contrast to PGE2 and TNF-, no IL-1 was
detected in the media from MdM infected with
either K or L2 biovars. These results differ from
those reported by Rothermel et al.,
36 who showed
that C. trachomatis induced production of IL-1 by
human monocytes. This difference might be due to
the difference in the M.O.I. used by Rothermel as
compared to the M.O.I. in our system (1-2) or to
the differentiation state of the cells used by
Rothermel (monocytes) compared to ours (MdM).
Roux Lombard et a/.37 showed that blood
monocytes cultured for several weeks, produced
much less IL-1 than freshly isolated monocytes.
Furthermore, they showed that monocytes cultured
for a few weeks produced a specific IL-1 inhibitor.
The level of TNF detected in the medium of the
t2 or K strains infected MdM reached a maximum
at 24 h post-infection and then declined (Fig. 2).
When the infected MdM were washed daily, the
TNF level remained high throughout the entire
experimental period (data not shown). A possible
explanation is that the high level ofPGE2 depressed
TNF production, and that washing the cells
eliminated the interference of PGE2. This explana-
tion is supported by Kunkel et al.8 who showed that
PGE2 regulates macrophage derived TNF gene
expression. These observations support the sugges-
tion that TNF and PGE. may affect each other’s
production.9’3 TNF produced by activated macro-
phages may be responsible for increased synthesis
of PGE2, which, in turn, limits macrophage
activation in an autoregulatory manner.24’25 A
delicate balance between TNF and PGE2 produced
by macrophages might play a major role in theC. trachomatis infected MdM, TNF and PGEe
outcome and severity of chlamydial infection in vivo.
Animal model studies are required to examine the
possible therapeutic effect of prostaglandin in-
hibitors and antibodies to TNF on the outcome of
chlamydial infections.
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